Albemarle Co. (NYSE:ALB) Short Interest Down 9.5% in November

Albemarle Co. (NYSE:ALBGet Free Report) was the recipient of a large decrease in short interest in November. As of November 15th, there was short interest totalling 12,340,000 shares, a decrease of 9.5% from the October 31st total of 13,630,000 shares. Based on an average daily trading volume, of 2,490,000 shares, the days-to-cover ratio is currently 5.0 days.

Analysts Set New Price Targets

ALB has been the subject of a number of research reports. Robert W. Baird dropped their target price on shares of Albemarle from $85.00 to $79.00 and set a “neutral” rating for the company in a report on Friday, October 25th. Royal Bank of Canada increased their price objective on Albemarle from $108.00 to $133.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. Piper Sandler cut their price target on shares of Albemarle from $95.00 to $90.00 and set an “underweight” rating on the stock in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Albemarle from $105.00 to $80.00 and set a “hold” rating for the company in a research report on Friday, August 16th. Finally, Evercore ISI lowered their price objective on Albemarle from $190.00 to $170.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 28th. One research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $114.47.

Read Our Latest Research Report on Albemarle

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Inspire Trust Co. N.A. lifted its position in shares of Albemarle by 9.9% during the 3rd quarter. Inspire Trust Co. N.A. now owns 11,120 shares of the specialty chemicals company’s stock worth $1,053,000 after buying an additional 1,000 shares during the period. Tidal Investments LLC raised its holdings in shares of Albemarle by 1.5% in the third quarter. Tidal Investments LLC now owns 18,457 shares of the specialty chemicals company’s stock valued at $1,748,000 after purchasing an additional 274 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Albemarle in the 3rd quarter valued at approximately $267,000. Rehmann Capital Advisory Group increased its holdings in shares of Albemarle by 5.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 4,542 shares of the specialty chemicals company’s stock worth $430,000 after acquiring an additional 228 shares during the last quarter. Finally, TD Private Client Wealth LLC raised its holdings in Albemarle by 50.4% in the 3rd quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company’s stock valued at $37,000 after acquiring an additional 132 shares during the period. 92.87% of the stock is owned by institutional investors and hedge funds.

Albemarle Stock Down 2.0 %

Albemarle stock traded down $2.23 during midday trading on Tuesday, hitting $109.07. The stock had a trading volume of 1,477,858 shares, compared to its average volume of 2,911,551. The stock has a market cap of $12.82 billion, a P/E ratio of -6.58 and a beta of 1.56. Albemarle has a 12 month low of $71.97 and a 12 month high of $153.54. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43. The business has a fifty day moving average price of $100.26 and a 200 day moving average price of $98.07.

Albemarle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, December 13th will be paid a dividend of $0.405 per share. The ex-dividend date is Friday, December 13th. This represents a $1.62 annualized dividend and a yield of 1.49%. Albemarle’s dividend payout ratio (DPR) is presently -9.67%.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Articles

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.